Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability

Table 2 Characteristics the participants in the investigation of validity and reliability

characteristics the participants	N		n(%)	Mean	SD
Age	134			59.69	12.7
Sex	134	male	73(54.5)
		female	61(45.5)
PS	133	0	11(8.3)
		1	84(63.2)
		2	19(14.3)
		3	19(14.3)
Caregiver	133	Yes	123(92.5)
		Unemployed	10(7.5)
Employment	132	Full-time employee	36(27.3)
		Part-time or contract employee	15(11.4)
		Unemployed	81(61.3)
Site of disease	133	Pancreas	25(18.8)
		Colon	19(14.3)
		Lungs	14(10.5)
		Stomach	13(9.8)
		Breasts	11(8.3)
		Liver/gallbladder	9(6.8)
		Esophagus	9(6.8)
		Head and neck	3(2.3)
		Uterus	3(2.3)
		Prostate	2(1.5)
		Thymus	2(1.5)
		Other	23(17.3)
Type of around-the-clock opioid	132	Oxycodone	101(76.5)
		Fentanyl	9(6.8)
		Morphine hydrochloride	1(0.8)
		Other	21(15.9)
As-needed opioid	130	Oxycodone	105(80.8)
		Fentanyl	5(3.8)
		Morphine hydrochloride	5(3.8)
		Other	15(11.5)
Daily morphine equivalent dose	124			48.02	59.55
Duration of opioid analgesics use	132			9.43	19.05

ISSN: 1472-684X